Experience

Davis Polk advised the forward purchasers and forward sellers in connection with an at-the-market forward underwriting program for the offer and sale of shares of common stock of AvalonBay…

Davis Polk advised the underwriters in connection with an initial public offering of 7,521,394 shares of common stock of NGM Biopharmaceuticals, Inc. at $16.00 per share, for gross proceeds…

Davis Polk advised the initial purchasers in connection with the offering by Sociedad Química y Minera de Chile S.A. of $450 million aggregate principal amount of its 4.250% notes due 2029…

Davis Polk advised Zai Lab Limited in connection with its follow-on offering of $230 million of American Depositary Shares representing 9,019,608 ordinary shares of the company. The ADSs…

Davis Polk advised the representative of the initial purchasers in connection with Rule 144A/Regulation S offerings by JBS USA Lux S.A., JBS USA Food Company and JBS USA Finance, Inc…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $64.8 million follow-on offering of common stock of Magenta Therapeutics,…

Davis Polk advised the representatives of the underwriters in connection with the $104.7 million initial public offering of 6,543,500 shares of common stock of TransMedics Group, Inc.,…

Davis Polk advised General Electric Company in connection with the SEC-registered secondary offering of 25,300,000 shares of common stock of Westinghouse Air Brake Technologies Corporation,…

Davis Polk advised Freeport-McMoRan Inc., PT Freeport Indonesia, a subsidiary of FCX, and Freeport-McMoRan Oil & Gas LLC in connection with an amendment to its $3.5 billion revolving…

Davis Polk advised Mongolian Mining Corporation (“MMC”) and Energy Resources LLC (“ER” and, together with MMC, the “Co-Issuers”), an indirect wholly owned subsidiary of MMC, in connection…